AAP
RETA

Aristotle Atlantic Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Aristotle Atlantic Partners’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,200
Closed -$245K – 101
2019
Q4 		$245K Buy
+1,200
New +$245K 0.03% 91